HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoxia Yuan Selected Research

Stomach Neoplasms (Stomach Cancer)

11/2023Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR-195-5p and ABCG2 pathway.
11/2022Phosphoglycerate mutase 1 that is essential for glycolysis may act as a novel metabolic target for predicating poor prognosis for patients with gastric cancer.
10/2022Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer.
2/2022Identification and validation of PGLS as a metabolic target for early screening and prognostic monitoring of gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoxia Yuan Research Topics

Disease

4Stomach Neoplasms (Stomach Cancer)
11/2023 - 02/2022
1Breast Neoplasms (Breast Cancer)
01/2023
1Cognitive Dysfunction
01/2022
1Liver Diseases (Liver Disease)
08/2012
1Jaundice (Icterus)
08/2012

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
11/2022 - 02/2022
2Indicators and Reagents (Reagents)IBA
11/2022 - 02/2022
2Biomarkers (Surrogate Marker)IBA
10/2022 - 08/2012
1Long Noncoding RNAIBA
11/2023
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2023
1Estrogens (Estrogen)FDA Link
01/2023
1IsoflavonesIBA
01/2023
1Phosphoglycerate Mutase (Phosphoglyceromutase)IBA
11/2022
1Ligases (Synthetase)IBA
10/2022
1AmmoniaIBA
10/2022
1Carbamyl Phosphate (Carbamoyl Phosphate)IBA
10/2022
1IsotopesIBA
10/2022
1Ornithine-Oxo-Acid Transaminase (Ornithine Aminotransferase)IBA
10/2022
16-phosphogluconolactonaseIBA
02/2022

Therapy/Procedure

1Tai Ji (Tai Chi Chuan)
01/2022